title: Oxidative stress and the regulation of complement activation in human glaucoma.
abstract: OBJECTIVE
  As part of ongoing studies on proteomic alterations during glaucomatous neurodegeneration, this study focused on the complement system.
  
  
  METHODS
  Human retinal protein samples obtained from donor eyes with (n = 10) or without (n = 10) glaucoma were analyzed by a quantitative proteomic approach using mass spectrometry. Cellular localization of protein expression for different complement components and regulators were also determined by immunohistochemical analysis of an additional group of human donor eyes with glaucoma (n = 34) compared with age-matched control eyes without glaucoma (n = 20). In addition, to determine the regulation of complement factor H (CFH) by oxidative stress, in vitro experiments were performed using rat retinal cell cultures incubated in the presence and absence of an oxidant treatment.
  
  
  RESULTS
  Proteomic analysis detected the expression and differential regulation of several complement components in glaucomatous samples, which included proteins involved in the classical and the lectin pathways of complement activation. In addition, several complement regulatory proteins were detected in the human retinal proteome, and glaucomatous samples exhibited a trend toward downregulation of CFH expression. In vitro experiments revealed that oxidative stress, which was also prominently detectable in the glaucomatous human retinas, downregulated CFH expression in retinal cells.
  
  
  CONCLUSIONS
  These findings expand the current knowledge of complement activation by presenting new evidence in human glaucoma and support that despite important roles in tissue cleaning and healing, a potential deficiency in intrinsic regulation of complement activation, as is evident in the presence of oxidative stress, may lead to uncontrolled complement attack with neurodestructive consequences.
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA. gulgun.tezel@louisville.edu
authors.forename: Gülgün
authors.initials: G
authors.lastname: Tezel
authors.forename: Xiangjun
authors.initials: X
authors.lastname: Yang
authors.forename: Cheng
authors.initials: C
authors.lastname: Luo
authors.forename: Angela D
authors.initials: AD
authors.lastname: Kain
authors.forename: David W
authors.initials: DW
authors.lastname: Powell
authors.forename: Markus H
authors.initials: MH
authors.lastname: Kuehn
authors.forename: Henry J
authors.initials: HJ
authors.lastname: Kaplan
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D015153:Blotting, Western; D002478:Cells, Cultured; D003167:Complement Activation / Q000187:drug effects / Q000502:physiology*; D003165:Complement System Proteins / Q000378:metabolism*; D015536:Down-Regulation; D019084:Fluorescent Antibody Technique, Indirect; D005902:Glaucoma, Open-Angle / Q000378:metabolism*; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007429:Intraocular Pressure; D018384:Oxidative Stress; D040901:Proteomics; D051381:Rats; D012160:Retina / Q000187:drug effects / Q000378:metabolism; D012165:Retinal Ganglion Cells / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D053719:Tandem Mass Spectrometry; D014019:Tissue Donors
chemical_list: D003165:Complement System Proteins; D006861:Hydrogen Peroxide